Janus International Group, Inc. — Form 8-K Summary
Reporting date: August 3, 2023; filed August 4, 2023. The filing reports a refinancing and related creation of direct financial obligations. No operating results or financial statements are included.
Financing and Liquidity
- The company completed an amendment to its First Lien Credit and Guarantee Agreement through a lender syndicate originating $625 million on August 3, 2023.
- The First Lien facility requires quarterly amortization equal to 0.25% of the original balance, beginning on the last business day of December 2023. Remaining principal is due at maturity on August 3, 2030.
- The company refinanced its prior asset-based lending facility with a new 2023 ABL Credit and Guarantee Agreement.
- ABL commitments increased from $80 million to $125 million. The new agreement also revised the borrowing-base methodology and appointed JPMorgan Chase Bank as administrative and collateral agent, with Bank of America and Goldman Sachs as syndication lenders.
- Interest on both facilities is payable in arrears, with First Lien interest timing dependent on the applicable loan type or interest period.
Material Changes and Covenants
- The refinancing replaced or amended the company’s prior First Lien and ABL arrangements and increased available ABL commitments by $45 million.
- The agreements contain customary affirmative and negative covenants, including restrictions on additional debt, liens, fundamental changes, dispositions, restricted payments, investments and affiliate transactions.
- The ABL facility includes a minimum fixed-charge coverage ratio covenant of 1.0 to 1.0 if excess availability falls below the specified threshold: the greater of 10% of the lesser of aggregate commitments or the borrowing base, and $10 million.
- The company may use an equity cure up to twice in any four-quarter period and up to five times over the life of the facility.
- As of July 1, 2023, the company stated that it was in compliance with the covenants governing its outstanding indebtedness.
Outlook, Risks and Unusual Items
The filing does not provide revenue, profit, cash flow, margin, leverage, interest-rate, liquidity-balance or other operating guidance. Key financial risks include required debt amortization, refinancing and maturity risk, variable interest expense, covenant compliance and potential limitations on corporate actions under the credit agreements. The filing does not state the use of proceeds or provide a clear value for debt outstanding immediately before or after the refinancing.
Investor Verification Checklist
- Review Exhibits 10.1 and 10.2 for interest-rate margins, fees, collateral, borrowing-base mechanics, mandatory prepayments, default provisions and detailed covenant exceptions.
- Verify the amount and terms of any debt repaid or refinanced, including whether the $625 million First Lien facility represents gross commitments or funded borrowings.
- Assess actual borrowing capacity and availability under the $125 million ABL facility.
- Review subsequent financial statements for debt balances, refinancing costs, cash interest expense and covenant headroom.
- Evaluate exposure to variable interest rates and the August 3, 2030 First Lien maturity.